The FDA issued an emergency use authorization (EUA) for the JYNNEOS vaccine to increase vaccine supply by up to five-fold and to allow for individuals under 18 years of age determined to be at high risk of monkeypox infection to receive the vaccine.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/punF5Js
No comments:
Post a Comment